Publications by authors named "Wayne Yates"

Claim this Profile
I
Impact of nebulization versus metered-dose inhaler utilization on viral particle dispersion in patients with COVID-19.
Brian M Clemency, Candice Clay, Renoj Varughese, Carli Kennedy, Wayne Yates

J Infect Prev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Dysfunction Quantified by HepQuant DuO Outperforms Child-Pugh Classification in Predicting the Pharmacokinetics of Ampreloxetine.
Jitendra Kanodia, Hugh Giovinazzo, Wayne Yates, David L Bourdet, Michael P McRae

Clin Pharmacol Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies.
Dean Quinn, Christopher N Barnes, Wayne Yates, David L Bourdet, Edmund J Moran

Pulm Pharmacol Ther· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteers.
Parnian Zia-Amirhosseini, Margaret Salfi, Philip Leese, Wayne Yates, Dimitry M Danilenko

Clin Pharmacol Ther· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation.
John G F Cleland, John T Sullivan, Stephen Ball, John D Horowitz, Balaji Agoram, Wayne Yates

J Cardiovasc Pharmacol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis